GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is rapidly gaining a prominent focus in therapeutic investigation, largely due to its notable impact on treating diseases such as second type diabetes and weight gain. Ongoing studies have shown that beyond glucose control, GLP-1 medications offer potential for heart function and perhap… Read More